Constipation in Children: IAP Guidelines

Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-04-07 14:30 GMT   |   Update On 2023-04-07 14:30 GMT

Chronic constipation in children is a very common and increasingly encountered problem in office practice. While <5% children with constipation have a definitive organic etiology (e.g., congenital, surgical, neurological, and endocrine conditions) for constipation, the vast majority of children have no proven cause and are labeled as functional constipation. The normal stool frequency...

Login or Register to read the full article

Chronic constipation in children is a very common and increasingly encountered problem in office practice. While <5% children with constipation have a definitive organic etiology (e.g., congenital, surgical, neurological, and endocrine conditions) for constipation, the vast majority of children have no proven cause and are labeled as functional constipation. The normal stool frequency in children is mentioned in Table 1.

TABLE 1: Defecation frequency in children.

Age

Average number of stools per day

<1 month

3–4

1 month to 1 year

1.5–2

1–2 years

1–2

2–18 years

1

Recognition of constipation is not based on stool frequency alone and the physician should assess other parameters like stool consistency/associated pain or struggle during defecation/associated fissure/soiling of underwear before labeling it as constipation.

The Indian Academy of Pediatrics (IAP) has released Standard Treatment Guidelines 2022 for Constipation in Children. The lead author for these guidelines on Constipation in Children is Dr. Srinivas S along with co-author Dr. Mohit Vohra and Dr. Vibhor Borkar. The guidelines come Under the Auspices of the IAP Action Plan 2022, and the members of the IAP Standard Treatment Guidelines Committee include Chairperson Remesh Kumar R, IAP Coordinator Vineet Saxena, National Coordinators SS Kamath, Vinod H Ratageri, Member Secretaries Krishna Mohan R, Vishnu Mohan PT and Members Santanu Deb, Surender Singh Bisht, Prashant Kariya, Narmada Ashok, Pawan Kalyan.

Following are the major recommendations of guidelines:

Functional constipation is considered when any of the two or more criteria to be fulfilled to label as constipation. The criteria include:

Stool frequency ≤2 per week

History of hard and painful bowel movements

History of retention of stools

Large diameter stool obstructing the Indian pots

Fecal incontinence

Per abdomen or per rectum examination reveals fecal mass.

Clinical Evaluation:

The history taking and examination must include information regarding time of onset of constipation, passage of meconium, growth and developmental milestones, and history of withholding in order to differentiate functional constipation from organic causes (Table 2).

The presence of a mass or palpable fecaloma on abdominal examination might suggest the presence of fecal impaction (inability to pass/evacuate hard and large diameter stools) which often causes abdominal pain or fecal soiling.

A perianal examination (for the presence of fissure/sentinel skin tags) and examination of the spinal area for any possible underlying spinal/neurological conditions is recommended.

The history taking should include the following points in detail:

Age of onset of symptoms: Surgical causes are more common in infantile onset constipation. Functional constipation typically occurs later.

Passage of meconium after birth: Delayed passage of meconium is observed with Hirschsprung's disease.

Stool characteristics: Amount, consistency, and frequency of stools.

Pain during defecation and blood streaks on stool or drops after stools may suggest presence of anal fissure.

Retentive postures during defecation are often a "habit" mostly seen in younger children with functional constipation who dread the act of passing painful stools.

Urinary symptoms: Increased frequency, burning micturition, and urinary incontinence may suggest coexisting urinary tract infection or voiding dysfunction.

TABLE 2: Red flag symptoms and signs pointing to common organic causes.

Signs and symptoms

Probable cause for constipation

Short stature, decrease in height velocity, delayed development/poor scholastics, lethargy, cold intolerance in older children

Hypothyroidism

Delayed passage or failure to pass meconium, failure to thrive, abdominal distension, history of recurrent enterocolitis

Hirschsprung's disease

Tuft of hair at back of the spine or any other abnormal neurological signs in lower limbs

Spinal cord abnormalities and spinal dysraphism

Significant perinatal history, delayed development, feeding abnormalities, regression of acquired milestones

Cerebral palsy and neurodegenerative disorder

Recurrent respiratory infections, meconium ileus, and failure to thrive

Cystic fibrosis

Management:
The diagnosis of functional constipation can be made with a good clinical history and physical examination and seldom needs many investigations. The presence of red flag signs often point toward an organic etiology and such children should be appropriately investigated. The management of constipation involves five components and is depicted in the Figure.
Source:Indian Academy of Pediatric Guidelines
1. Parental counseling and education:
• Parents need to be educated regarding the pathophysiology of functional constipation so that they understand why their child struggles to defecate and what needs to be done to improve the situation.
• The longer the stool is retained in the colon, the drier/harder and bulkier it becomes and this causes painful evacuation. The withholding behavior of a child often begins after such a painful movement of the bowel and when this continues for a period of time; it establishes a vicious cycle that leads to chronic habitual constipation.
• This can lead to fecal impaction/overflow incontinence when left untreated. Longstanding constipation (left untreated for several months) in a small percentage of children can lead to the development of a secondary megarectum.
• These children require specialist attention, evaluation, and several months of effective laxative therapy before the megarectum and constipation resolve.
Emphasis also should be given to the need for compliance and regular medical follow-up until complete recovery. Parental anxiety regarding the side effects of long-term osmotic laxatives should be allayed.
2. Diet, fiber, and water intake:
• The daily diet should include a sufficient quantity of fiber (0.5 g/kg/day) and adequate water. It should be noted that milk has a minimal quantity of fiber. The daily diet should include cereals, pulses, vegetables, and fruits.
• Milk however may be allowed in permissible quantities as per child's age. It is important to provide symptom relief to the child with medications and not rely on diet alone to treat a child with chronic constipation.
3. Physical activity: Sedentary lifestyle is discouraged and participation in physical activities are encouraged as this encourages bowel movement.
4. Toilet training: The parents are advised to encourage their child to defecate within 30 minutes of the major meal in order to utilize gastrocolic reflex. If the child uses Western toilet, the child should be encouraged to use a footrest to make an effective angulation between abdomen and thighs to facilitate proper passage of stools. (The Indian style closet is considered anatomically more ideal for defecation than the Western style closet).
5. Medical therapy: Medical therapy includes disimpaction and maintenance.
Identification and Treatment of Fecal Impaction :
A significant proportion of children with long-standing constipation often have very hard and impacted stools, which may not be cleared with regular/maintenance dose laxatives. Identification of fecal impaction and disimpaction with laxatives is an important initial requisite for subsequent effective maintenance laxative therapy. Different regimes are mentioned in Table 3. Oral agents are preferred over rectal agents.

TABLE 3: Different regimens used for fecal disimpaction.

Home-based disimpaction regimen

Dosage

Side effects/comments

Polyethylene glycol

1.5–2 g/kg/day in two divided doses for 3–6 days

Well tolerated but slower to act

Oral agent— Polyethylene glycol

25 mL/kg/h orally or by nasogastric tube over 4–6 hours

  • Requires admission
  • Ensures disimpaction of the entire colon within a few hours
  • May cause bloating, abdominal

distension, and nausea

Rectal agent, e.g., sodium phosphate enemas

2.5 mL/kg (2–18 years old)

Maintenance Therapy:
The two classes of laxatives used in the maintenance phase are osmotic laxative and stimulant laxatives (Table 4).
Osmotic laxatives are the preferred first choice of the pediatric medical fraternity due to: (1) extensive experience and published literature and (2) better side effect profile.
Successful treatment is defined as regular painless defecation, achievement of toilet training, and absence of fecal soiling or blood in stools. Stool diary is a useful monitoring tool that often ensures better compliance.
The tapering of laxative dose is usually started after 2–3 months of successful treatment and continued over a period of 2–3 months.
Avoid abrupt stopping of the laxatives. Stimulant laxatives such as senna and bisacodyl are often used as a rescue therapy for 2–3 days whenever children suffer from relapse of acute constipation while on maintenance therapy.
The children who do not respond to the sustained optimal treatment should be referred for expert opinion.

TABLE 4: Commonly used laxatives and dose used in children and their mechanism of action.

Types of laxatives

Name of laxative

Dose

Mechanism of action

Side effect

Osmotic laxatives

Polyethylene glycol

0.5–1 g/kg/day

Large inert molecule which retains intraluminal water

Nausea and bloating

Lactulose

<1 year 2.5 mL BD

1–<5 years:

2.5–10 mL BD

5–20 years

5–20 mL BD

Nonabsorbable synthetic disaccharides product which retains intraluminal water

Bloating and abdominal discomfort

Lactitol

200–400 mg/kg/ day

Synthetic monohydrate product which retains intraluminal water

Mild bloating

Stimulant laxatives

Sodium picosulfate

2.5–10 mg per day up to 4 years 2.5–20 mg per day up from

4–18 years

Converts into active metabolite by intestinal bacteria which increases the peristalsis

Nausea, crampy abdominal pain, occasionally loose motions

Points to Remember:
  • The diagnosis of functional constipation may be considered in the absence of red flag signs.
  • Organic causes are more common in infantile onset constipation.
  • Identification and treatment of fecal impaction is important for successful maintenance laxative therapy.
  • Long-term maintenance laxative therapy along with toilet training is often needed for best outcome.
  • Education and counseling of parents is important to ensure compliance and successful outcomes.
  • Refractory constipation should be referred to a pediatric gastroenterologist for further evaluation.
Reference:
  • Sujatha B, Velayutham DR, Deivamani N, Bavanandam S. Normal bowel pattern in children and dietary and other precipitating factors in functional constipation. J Clin Diagn Res. 2015;9(6): SC12-5.
  • Tabbers MM, DiLorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-74.
  • Yachha SK, Srivastava A, Mohan N, Bharadia L, Sarma MS, Indian Society of Pediatric Gastroenterology, et al. Management of Childhood Functional Constipation: Consensus Practice Guidelines of Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition and Pediatric Gastroenterology Chapter of Indian Academy of Pediatrics. Indian Pediatr. 2018;55(10):885-92.

The guidelines can be accessed on the official site of IAP: https://iapindia.org/standard-treatment-guidelines/

Tags:    
Article Source : Indian Academy of Pediatric, IAP Guidelines

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News